AUDITED RESULTS FOR FINANCIAL YEAR ENDED 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.2 pts more than Nifty Microcap 250 and 5.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Resonance Specialties reported strong full-year performance with revenue from operations growing 16% to Rs 9,024.75 lakh (FY25: Rs 7,780.66 lakh). Profit before tax jumped 58.5% to Rs 1,407.35 lakh, while PAT surged 58.3% to Rs 1,039.58 lakh. EPS improved to Rs 9.01 from Rs 5.69. The Board recommended a 10% dividend (Rs 1/share). Geographically, export revenue grew 57% to Rs 5,355 lakh and now accounts for 59% of total sales versus 44% last year, indicating successful international expansion. Operating cash flow was robust at Rs 1,731.72 lakh. The audit report was issued with an unmodified (clean) opinion, and auditors Kailash Chand Jain & Co. were reappointed for another 5 years. A new labour code impact of Rs 10.40 lakh was charged.
The company delivered robust double-digit revenue growth and near-60% profit growth, signaling operational efficiency. The clean audit opinion and strong cash generation are positives for investors. Export-led growth reduces domestic dependency risk.